CM-2433

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCM-2433
Drug Alias Namecholine analogs (Medical College Georgia/Cenomed)CB-2433JAY-22233JAY-22129CM-2433
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitorsImidazoline receptor modulatorsNerve growth factor receptor Trk-A activators +[6] 
TargetsNerve growth factor receptor Trk-AAcetylcholinesteraseNeuronal acetylcholine receptor protein alpha-7 subunit +[5] 
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedical College of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedical College of GeorgiaAbraxis BioScience LLC
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A